MUDA site allotment case: Karnataka HC rejects plea to transfer probe to CBI
Justice M Nagaprasanna ruled that there was no evidence to suggest that the ongoing investigation by Lokayukta police was ...
Tango Therapeutics CEO Barbara Weber sells $57,710 in stock
BOSTON—Barbara Weber, the Chief Executive Officer of Tango Therapeutics, Inc. (NASDAQ:TNGX), a $350 million market cap biotech company, recently sold a portion of her holdings in the company.
STAT11h
Crisis in CRISPR world, RFK Jr.’s promises, and a novel non-opioid pain drug
Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...
Smithsonian Magazine12h
FDA Approves Transplant Trials for Gene-Edited Pig Kidneys
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
today.ucsd14h
AI Accelerates the Search for New Tuberculosis Drug Targets
The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...
GAT-B Exam 2025 Registration Begins at exams.nta.ac.in, Exam On April 20
The last date to apply for GAT-B 2025 is March 3, 2025. The application correction window will remain open on March 5 and 6.
3 Top AI-Powered Biotech Stocks to Buy in February
AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
FierceBiotech17h
Kura and Kyowa hail phase 2 win for leukemia drug soon heading to FDA, but hold back data
Kura and Kyowa used the announcement to confirm that they are on track to file a new drug approval application with the FDA ...
STAT18h
AstraZeneca offers some reassurance on China challenges
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...